Identification of a novel partner gene, TPR, fused to FGFR1 in 8p11 myeloproliferative syndrome

The 8p11 myeloproliferative syndrome (EMS) is an aggressive neoplasm caused by the fusion of various partner genes to fibroblast growth factor receptor 1 (FGFR1). Various FGFR1 fusions are associated with subtly distinct disease phenotypes. Here, we report a new translocation at the FGFR1 locus in a...

Full description

Saved in:
Bibliographic Details
Published inGenes chromosomes & cancer Vol. 51; no. 9; pp. 890 - 897
Main Authors Li, Feng, Zhai, Yong-Ping, Tang, Yu-Mei, Wang, Li-Ping, Wan, Pin-Jun
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.09.2012
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The 8p11 myeloproliferative syndrome (EMS) is an aggressive neoplasm caused by the fusion of various partner genes to fibroblast growth factor receptor 1 (FGFR1). Various FGFR1 fusions are associated with subtly distinct disease phenotypes. Here, we report a new translocation at the FGFR1 locus in a patient who carried t(1;8)(q25;p11.2) and presented with myeloproliferative neoplasm‐like symptoms. The patient was characterized by myeloid hyperplasia of bone marrow, markedly elevated numbers of monocytes, and normal to mildly elevated eosinophils. Initial fluorescent in situ hybridization analysis confirmed that FGFR1 in this patient was disrupted. Subsequent analysis led to the identification of a novel translocation, in which exon 23 of the translocated promoter region (TPR) gene at chromosome band 1q25 was fused to exon 13 of FGFR1 (RefSeq NM_0231102.2). The TPR portion of the fusion protein contains putative functional motifs including an N‐terminal TprMet domain, nuclear pore complexes associating domain, and multiple coiled‐coil domains. It is likely that one or more of the motifs from TPR contribute to dimerization, resulting in constitutive activation of the FGFR1 kinase domain. Our results further support a critical role of FGFR1 in the pathogenesis of EMS and may lead to more accurate diagnosis and potential targeted therapy. © 2012 Wiley Periodicals, Inc.
Bibliography:istex:C3B1353191ECCDA15B9A3CAD3EDD87CA1900BC19
ArticleID:GCC21973
Jinling Hospital of Nanjing - No. 2010Q022
ark:/67375/WNG-ZLDX6TFW-0
Feng Li and Yong‐Ping Zhai contributed equally to this work.
ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:1045-2257
1098-2264
DOI:10.1002/gcc.21973